Continuous cardiac monitoring in a patient with terminal pulmonary hypertension and eventual bilateral lung transplantation
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Continuous cardiac monitoring in a patient with terminal pulmonary hypertension and eventual bilateral lung transplantation. / Andersen, Mads Ørbæk; Diederichsen, Soeren; Svendsend, Jesper Hastrup; Carlsen, Jørn.
I: BMJ Case Reports, Bind 15, Nr. 6, e248304, 2022.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Continuous cardiac monitoring in a patient with terminal pulmonary hypertension and eventual bilateral lung transplantation
AU - Andersen, Mads Ørbæk
AU - Diederichsen, Soeren
AU - Svendsend, Jesper Hastrup
AU - Carlsen, Jørn
N1 - Publisher Copyright: © BMJ Publishing Group Limited 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
PY - 2022
Y1 - 2022
N2 - As pulmonary arterial hypertension (PAH) progress, arrhythmias are becoming an increasingly prominent phenomenon. Supraventricular tachycardias have been shown to have an incidence of up to 35% in pulmonary hypertension. Continuous cardiac monitoring was deployed in a patient with severe PAH 100 days before bilateral lung transplantation (BLTX). Despite being graded as WHO functional class IV, no arrhythmias were observed before BLTX. Furthermore, the case describes clinical improvement, along with a significant increase in heart rate variability (HRV) and decrease in night-time heart rate in the post-transplantation period. No arrhythmias were observed preoperatively during continuous monitoring in a 100-day period despite the patient's intrinsically high risk for arrhythmias. Increasing HRV and lower resting heart rate were observed after BLTX. Since these parameters correlate with the clinical condition, they might be valuable in risk assessment in patients with pulmonary hypertension.
AB - As pulmonary arterial hypertension (PAH) progress, arrhythmias are becoming an increasingly prominent phenomenon. Supraventricular tachycardias have been shown to have an incidence of up to 35% in pulmonary hypertension. Continuous cardiac monitoring was deployed in a patient with severe PAH 100 days before bilateral lung transplantation (BLTX). Despite being graded as WHO functional class IV, no arrhythmias were observed before BLTX. Furthermore, the case describes clinical improvement, along with a significant increase in heart rate variability (HRV) and decrease in night-time heart rate in the post-transplantation period. No arrhythmias were observed preoperatively during continuous monitoring in a 100-day period despite the patient's intrinsically high risk for arrhythmias. Increasing HRV and lower resting heart rate were observed after BLTX. Since these parameters correlate with the clinical condition, they might be valuable in risk assessment in patients with pulmonary hypertension.
KW - Arrhythmias
KW - Pulmonary hypertension
U2 - 10.1136/bcr-2021-248304
DO - 10.1136/bcr-2021-248304
M3 - Journal article
C2 - 35667702
AN - SCOPUS:85131344844
VL - 15
JO - BMJ Case Reports
JF - BMJ Case Reports
SN - 1757-790X
IS - 6
M1 - e248304
ER -
ID: 323983544